human breast breast adenocarcinoma 231 psn1 crm crl human pancreas pancreas 3211 adenocarcinoma pc 3 crl (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
99
Structured Review
ATCC
human breast breast adenocarcinoma 231 psn1 crm crl human pancreas pancreas 3211 adenocarcinoma pc 3 crl
Human Breast Breast Adenocarcinoma 231 Psn1 Crm Crl Human Pancreas Pancreas 3211 Adenocarcinoma Pc 3 Crl, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 14582 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/psn1/PC-3/us12653900-838-23-4
Average 99 stars, based on 14582 article reviews
Human Breast Breast Adenocarcinoma 231 Psn1 Crm Crl Human Pancreas Pancreas 3211 Adenocarcinoma Pc 3 Crl, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 14582 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/psn1/PC-3/us12653900-838-23-4
Average 99 stars, based on 14582 article reviews
human breast breast adenocarcinoma 231 psn1 crm crl human pancreas pancreas 3211 adenocarcinoma pc 3 crl - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Cell Culture:Article Title: Targeting class I HDACs suppresses oncogenic vulnerabilities and potentiates KRAS/MAPK pathway inhibitors in KRAS-mutant cancers. Article Snippet: .. Cell lines and cell culture Human pancreas cancer cell lines MIA PaCa-2, HPAF-II, Article Title: Thiosemicarbazone compounds and uses thereof Article Snippet: .. Cell culture and culture conditions: Pancreatic adenocarcinoma cell lines: PATU8988T, MIAPACA2, SU8686, Multiple Displacement Amplification:Article Title: Targeting class I HDACs suppresses oncogenic vulnerabilities and potentiates KRAS/MAPK pathway inhibitors in KRAS-mutant cancers. Article Snippet: .. Cell lines and cell culture Human pancreas cancer cell lines MIA PaCa-2, HPAF-II, other:Article Title: Mutant and Wild-type RAS Crosstalk and Stoichiometric Deficiencies are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma Article Snippet: HPAC 12 (RRID:CVCL_3517), SW 1990 (RRID:CVCL_1723), PANC-1(RRID:CVCL_0480), Article Title: Thiosemicarbazone compounds and uses thereof Article Snippet: Pancreatic adenocarcinoma cell lines: PATU8988T, MIAPACA2, SU8686, PSN1, HPAC, BXPC3, DANG, SUIT2, A13A, CAPAN2, T3M4, A2.1, HUPT4, XWR200, L36PL, YAPC, PANC0327, PANC1, PATU8902, HPAF11, ASPC1, PANC0813, PANC0203, HS766T, SW1990, and CFPAC1; prostate cancer cell lines: 22Rv1, LNCaP, RM1 and C4-2; and small cell lung carcinoma cell lines: NCI-H526, NCI-H146, and |